| Net Cash Provided by (Used in) Operating Activities |
$-13,679 |
USD |
63% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
62,379,759 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$240,748 |
USD |
-22.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2023 |
Q1 2023 |
| Deferred Tax Assets, Valuation Allowance |
$309,675 |
USD |
7.7% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$309,675 |
USD |
7.7% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
4,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$8,839,367 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |